TORONTO, ON / ACCESSWIRE / December 15, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and electrocardiogram ("ECG") ...
Please provide your email address to receive an email when new articles are posted on . In a cohort of 487 patients with lupus but without cardiovascular disease, 21.4% had electrocardiogram-4 ...
Please provide your email address to receive an email when new articles are posted on . Cardiac Insight, a digital healthcare company specializing in wearable technology and automated ECG analysis, ...
HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New ...
(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, announced a commercial partnership with ClearCardio (TM), a leading preventive ...
1. The expanded indications allow clinicians to use the Apple Watch as a remote monitoring ECG device during public health emergencies such as the COVID-19 pandemic. Healthcare providers can access ...
Abstract and Introduction Employment of ECG in HF: Current State of the Art Employment of ECG in HF: A Proposal References Employment of ECG in HF: Current State of the Art The ECG is presently always ...
A purported video of a lab attendant performing an ECG scan on a patient after a watching YouTube clip at Jodhpur's state-run hospital has surfaced on social media, prompting the administration to ...
HeartBeam, Inc. BEAT shares are trading higher Tuesday after the company announced a strategic partnership with Mount Sinai to accelerate the joint development and validation of next-generation AI-ECG ...
Asianet Newsable on MSN
HeartBeam announces first patient enrollments in heart attack detection pilot study
HeartBeam’s technology uniquely capable of assessing possible heart attacks outside of traditional clinical settings ALIGN-ACS study expected to complete patient enrollment quickly Milestone signifies ...
An NHS test to assess a patient's risk of heart attack is worthless, a study has found. The electrocardiogram, which records the electrical impulses produced by a heart's rhythm, is not accurate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results